DOTmed January 13, 2021
Robin Lasky

Adding Microsoft as a collaborator, Verily and the Broad Institute of MIT and Harvard have a powerful new partner in their efforts to enhance Terra, their open-source biomedical research platform.

Already used by thousands of health and life science researchers, Terra is a secure, open-sourced platform used to access, share, and analyze biomedical data. Now, with the addition of Microsoft’s Azure cloud and AI machine learning technologies, more than 168,000 researchers around the globe may be able to access data, run analysis tools and collaborate.

“Our three organizations share the goals of improving patient care, driving innovation in biomedical research, and lowering costs across healthcare and life sciences,” said Stephen Gillett, chief operating officer at Verily, in a statement. “This...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Technology
BMS plans $1.5B in cuts through '25, with 2000-plus layoffs
Big Pharma's ROI for drug R&D saw 'welcome' rebound in 2023: report
STAT+: Why a British hospital, and not a drugmaker, is trying to get a rare disease therapy approved
STAT+: Profiting from ‘legal’ insider trading isn’t always easy
Regeneron expands in gene editing with Mammoth deal

Share This Article